semaglutide and masld Long-term real-life experience of in a monocentric cohort with type 2 diabetes metabolic dysfuction-associated steatotic liver disease (MASLD) Mechanism of Semaglutide in MASLD

Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review

Whats not so easy is understanding how activated methyl-folate plays a key role in a biochemical process called methylation

Interestingly, despite its widespread use for weight loss today, Ozempic is not FDA-approved for that purpose

Read here: via Stockhead Recce Pharmaceuticals Ltd has advanced its RECCE 327 Topical Gel program into a pivotal Phase III trial for diabetic foot infections in Australia after receiving Human Research Ethics Committee approval for a major protocol expansion

Enter Retatrutide Retatrutide is the first triple agonist targeting 3 metabolic receptors at once: GLP-1: Enhances insulin, reduces appetite, slows digestion GIP: Boosts insulin, improves lipid metabolism GCGR: Increases energy expenditure, burns fat GLP-1 activation stimulates insulin secretion from pancreatic -cells, reduces appetite through central pathways, and slows gastric emptying to reduce glucose spikes

Weight loss can be challenging